Health Condition 1: C501- Malignant neoplasm of central portion of breast Health Condition 2: C503- Malignant neoplasm of lower-innerquadrant of breast Health Condition 3: C505- Malignant neoplasm of lower-outerquadrant of breast Health Condition 4: C502- Malignant neoplasm of upper-innerquadrant of breast Health Condition 5: C504- Malignant neoplasm of upper-outerquadrant of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.More than 18 years with breast cancer 2.American society of anesthesiologists physical status I to III. 3.patients who have given informed written consent.
Exclusion criteria
Exclusion criteria: Body mass index more than 40 Local anaesthetic allergy Local infection at the site of block Respiratory or neurological disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To document and compare cumulative opioid consumption intraoperatively and 24 hours postoperatively in all 4 groupsTimepoint: To document and compare cumulative opioid consumption intraoperatively and 24 hours postoperatively in all 4 groups | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Time of first rescue analgesic 2.Interval between opioid doses. 3.NRS score at rest,6,12,18,24 hours. 4.Complications of each technique 5.Postoperative nausea and vomiting 6.HemodynamicsTimepoint: During surgery and 24 hours post surgery. | — |
Countries
India
Contacts
NARAYANA HRUDHAYALAYA LTD.